MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma

Cellular Oncology

Volumn 36, Issue 5, 2013, Pages 385-394

  Wang, Yuanyuan ^a   Li, Min ^a   Zang, Wenqiao ^a   Ma, Yunyun ^a   Wang, Na ^a   Li, Ping ^b   Wang, Tao ^b   Zhao, Guoqiang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Esophageal cancer; Invasion; MiR 429; SP1

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 429; PROTEIN BCL 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; BINDING SITE; CELL GROWTH; CLINICAL ARTICLE; DOWN REGULATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; SP1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84892698663     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0144-6     Document Type: Article

References (45)

1. M. Abdelrahim, R. Smith 3rd, R. Burghardt, Safe S Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res. 64(18), 6740-6749 (2004)
2. J. Brennecke, S.M. Cohen, Towards a complete description of the microRNA complement of animal genomes. Genome Biol 4(9), 228 (2003)
3. G.A. Calin, C.M. Croce, MicroRNA signatures in human cancers. Nat. Rev. Cancer 6(11), 857-866 (2006)
4. J.A. Chan, A.M. Krichevsky, K.S. Kosik, MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65(14), 6029-6033 (2005)
5. W.S. Dynan, R. Tjian, The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35(1), 79-87 (1983)
6. P.C. Enzinger, R.J. Mayer, Esophageal cancer. N. Engl. J. Med. 349(23), 2241-2252 (2003)
7. M. Esteller, Non coding RNAs in human disease. Nat. Rev. Genet. 12(12), 861-874 (2011)
8. Y. Gao, Z. Chen, L. Zhang, F. Zhou, S. Shi, X. Feng, B. Li, X. Meng, X. Ma,M. Luo, K. Shao, N. Li, B. Qiu, K. Mitchelson, J. Cheng, J. He, Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 68(1), 26-33 (2008)
9. Y. Han, J. Chen, X. Zhao, C. Liang, Y. Wang, L. Sun, Z. Jiang, Z. Zhang, R.Yang, J. Chen, Z. Li,A. Tang, X. Li, J.Ye, Z. Guan,Y.Gui, Z. Cai, MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6(3), e18286 (2011)
10. H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu,K. Franssila, S. Suster, R.T.Kloos, C.M. Croce, A. de la Chapelle, The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U. S. A. 102(52), 19075-19080 (2005)
11. M.V. Iorio, M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Ménard, J.P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G.A. Calin, P. Querzoli, M. Negrini, C.M. Croce, MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65(16), 7065-7070 (2005)
12. M.V. Iorio, R. Visone, L.G. Di, V. Donati, F. Petrocca, P. Casalini, C. Taccioli, S. Volinia, C.G. Liu, H. Alder, G.A. Calin, S.Ménard, C.M. Croce, MicroRNA signatures in human ovarian cancer. Cancer Res. 67(18), 8699-8707 (2007)
13. R.H. Jensen, M. Tiirikainen, L. You, D. Ginzinger, B. He, K. Uematsu, Z. Xu, P. Treseler, F. McCormick, D.M. Jablons, Genomic alterations in human mesothelioma including high resolution mapping of common regions of DNA loss in chromosome arm 6q. Anticancer Res 23(3B), 2281-2289 (2003)
14. I.K. Kim, Y.K. Jung, D.Y. Noh, Y.S. Song, C.H. Choi, B.H. Oh, E.S. Masuda, Y.K. Jung, Functional screening of genes suppressing TRAIL-induced apoptosis: Distinct inhibitory activities of Bcl-XL and Bcl-2. Br. J. Cancer 88(6), 910-917 (2003)
15. L.M. Kong, C.G. Liao, F. Fei, X. Guo, J.L. Xing, Z.N. Chen, Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci. 101(6), 1463- 1470 (2010)
16. A. Kozomara, S. Griffiths Jones, miRBase: Integrating microRNA annotation and deep Sequencing data. Nucleic Acids Res. 39, D152- 157 (2011)
17. B.P. Lewis, C.B. Burge, D.P. Bartel, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120(1), 15-20 (2005)
18. J.S. Mattick, I.V. Makunin, Small regulatory RNAs in mammals. Hum. Mol. Genet. 14(Spec No1), R121-R132 (2005)
19. E.J. Nam, H. Yoon, S.W. Kim, H. Kim, Y.T. Kim, J.H. Kim, J.W. Kim, S. Kim, MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res 14(9), 2690-2695 (2008)
20. P.N. Kelly, A. Strasser, The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 18(9), 1414- 1424 (2011)
21. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA Cancer J. Clin 55(2), 74-108 (2005)
22. M. Sarbia, F. Bittinger, R. Porschen, P. Verreet, P. Dutkowski, R. Willers, H.E. Gabbert, bcl-2 expression and prognosis in squamous cell carcinomas of the esophagus. Int. J. Cancer 69, 324-328 (1996)
23. M. Torzewski, M. Sarbia, H. Heep, P. Dutkowski, R. Willers, H.E. Gabbert, Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Clin. Cancer Res 577(4), 577-583 (1998)
24. D.D. Patel, J.M. Bhatavdekar, P.R. Chikhlikar, Y.V. Patel, N.G. Shah, N. Ghosh, T.P. Suthar, D.B. Balar, Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: An immunohistochemical approach. J. Surg. Oncol 65(2), 111-116 (1997)
25. S. Safe, M. Abdelrahim, Sp transcription factor family and its role in cancer. Eur. J. Cancer 41(16), 2438-2448 (2005)
26. A.J. Schetter, S.Y. Leung, J.J. Sohn, K.A. Zanetti, E.D. Bowman, N. Yanaihara, S.T. Yuen, T.L. Chan, D.L. Kwong, G.K. Au, C.G. Liu, G.A. Calin, C.M. Croce, C.C. Harris,MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299(4), 425-436 (2008)
27. R. Schickel, B. Boyerinas, S.M. Park, M.E. Peter, MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27(45), 5959-5974 (2008)
28. Q. Shi, X. Le, J.L. Abbruzzese, Z. Peng, C.N. Qian, H. Tang, Q. Xiong, B. Wang, X.C. Li, K. Xie, Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61(10), 4143-4154 (2001)
29. J. Snowdon, X. Zhang, T. Childs, V.A. Tron, H. Feilotter, The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One 6(8), e22828 (2011)
30. U.T. Sankpal, P. Maliakal, D. Bose, O. Kayaleh, D. Buchholz, R. Basha, Expression of specificity protein transcription factors in pancreaticcancer and their association in prognosis and therapy. Curr. Med. Chem. 19(22), 3779-86 (2012)
31. T. Sun, C.Wang, J. Xing, D.Wu,MiR-429 modulates the expression of c-myc in human gastric carcinoma cells. Eur. J. Cancer 47(17), 2552-2559 (2011)
32. G. Suske, E. Bruford, S. Philipsen,Mammalian SP/KLF transcription factors: Bring in the family. Genomic 85(5), 551-556 (2005)
33. R.Nagadia, P. Pandit,W.B. Coman, J. Cooper-White, C. Punyadeera, miRNAs in head and neck cancer revisited. Cell Oncol 36(1), 1-7 (2013)
34. S.F. Tavazoie, C. Alarcón, T. Oskarsson, D. Padua, Q.Wang, P.D. Bos, W.L. Gerald, J. Massagué, Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175), 147-152 (2008)
35. J. Tie, D. Fan, Big roles of microRNAs in tumorigenesis and tumor development. Histol. Histopathol 26(10), 1353-1361 (2011)
36. S. Uhlmann, J.D. Zhang, A. Schwäger, H. Mannsperger, Y. Riazalhosseini, S. Burmester, A. Ward, U. Korf, S. Wiemann, O. Sahin, MiR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29(30), 4297-4306 (2010)
37. M. Van Kouwenhove, M. Kedde, R. Agami, MicroRNA regulation by RNA binding proteins and its implications for cancer. Nat. Rev. Cancer 11(9), 644-656 (2011)
38. K. Manav, Y. Kang, The emerging role of miR-200 family of microRNAs in epithelialmesenchymal transition and cancer metastasis. RNA Biol. 5(3), 115-119 (2008)
39. P. Sun-Mi, A.B. Gaur, E. Lengyel, M.E. Peter, The miR-200 family determines the epithelial phenotype of cancer cells by targeting the Ecadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008)
40. L.Wang, D.Wei, S. Huang, Z. Peng, X. Le, T.T.Wu, J. Yao, J. Ajani, K. Xie, Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 9(17), 6371- 6380 (2003)
41. B.Wightman, I. Ha, G. Ruvkun, Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75(5), 855-862 (1993)
42. N. Yanaihara, N. Caplen,E.Bowman, M. Seike, K.Kumamoto,M.Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, C.M. Croce, C.C. Harris, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3), 189-198 (2006)
43. L.Q. Yang, D.C. Fang, R.Q. Wang, S.M. Yang, Effect of NF-κB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J. Gastroenterol 10(1), 22-25 (2004)
44. J.C. Yao, L. Wang, D. Wei, W. Gong, M. Hassan, T.T. Wu, P. Mansfield, J. Ajani, K. Xie, Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res. 10(12 Pt 1), 4109-4117 (2004)
45. P.D. Zamore, B. Haley, Ribo-gnome: The big world of small RNAs. Science 309(5740), 1519-1524 (2005)